Royal Bank of Canada
IRWD icon

Royal Bank of Canada’s Ironwood Pharmaceuticals IRWD Stock Holding History

Royal Bank of Canada’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-29,850
Closed -$324K – 6231
2014
Q3 		$324K Buy
+29,850
New +$342K ﹤0.01% 3846

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royal Bank of Canada's IRWD Position: Q1 2026 in Review

Royal Bank of Canada reduced its Ironwood Pharmaceuticals (IRWD) stake by 72% in Q1 2026, selling an estimated $15.8K and leaving 1,461 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #6421.

Royal Bank of Canada first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $693K in Q3 2021. 227 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Royal Bank of Canada held 1,461 shares of Ironwood Pharmaceuticals worth $5K as of Q1 2026.
  • Royal Bank of Canada sold 3,849 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $15.8K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6421 holding.
  • Royal Bank of Canada first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Ironwood Pharmaceuticals position peaked at $693K in Q3 2021.
  • 227 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.